Amoxicillin Introduction: Mechanism of action: Pharmacology: Indications: Dosage: 12 Weeks ( 3 Months):

Similar documents
AMOCLAN HIKMA PHARMACEUTICALS

WARCLOX Capsules. (Amoxicillin/Cloxacillin) DESCRIPTION

SUMMARY OF PRODUCT CHARACTERISTICS

Staphylex Flucloxacillin (sodium)

Augmentin (Amoxicillin-clavulanate) Sachets

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

APO-FLUCLOXACILLIN CAPSULES. sodium salt of 3-(2'-chloro-6'-fluorophenyl)-5-methyl-4-isoxazolylpenicillin monohydrate.

Co amoxiclav. (Amoxicillin/Clavulanate Potassium)

See 17 for PATIENT COUNSELING INFORMATION Revised: 06/2016

Staphylex Flucloxacillin (as sodium) PRODUCT INFORMATION

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

NEW ZEALAND DATA SHEET

Therios 300 mg and 750 mg Palatable Tablets for Dogs

B. PACKAGE LEAFLET 1

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

NEW ZEALAND DATA SHEET. FLUCIL Flucloxacillin (as flucloxacillin sodium) Powder for Injection 500 mg & 1 g

Pharmacology Week 6 ANTIMICROBIAL AGENTS

1. WHAT CO-AMOXICLAV TABLETS IS AND WHAT IT IS USED FOR

ANTIBIOTICS. SCHOOL AGE AND ADOLESCENCE Respiratory viruses Respiratory viruses Respiratory viruses Streptococcus pneumoniae

Reference ID:

OCTOBER 2017 DRUG ANTIBIOTICS CELLULITIS IN CHILDREN

ANTIBIOTICS ACUTE OTITIS MEDIA (AOM) IN CHILDREN 3 MONTHS OF AGE OR OLDER GENERAL INFORMATIONS PREVENTIVE MEASURES DIAGNOSIS

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg film-coated tablets. amoxicillin/ clavulanic acid

AUSTRALIAN PRODUCT INFORMATION APO-AMOXYCILLIN (AMOXICILLIN TRIHYDRATE) POWDER FOR SUSPENSION

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

Active Constituent: Each tablet contains 500 mg cephalexin (as monohydrate) Contents: 12 [100, 300] Tablets

Veterinary Medicinal Product

Active Constituent: Each tablet contains 1000 mg cephalexin (as monohydrate) Contents: 8 [100, 300] Tablets

2 What you need to know before you take Augmentin

Package leaflet: Information for the patient. Co-amoxiclav 250 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

PRODUCT INFORMATION. FLOPEN (flucloxacillin)

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

PACKAGE LEAFLET: INFORMATION FOR THE USER

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci

SUMMARY OF PRODUCT CHARACTERISTICS

Clavulin 125 Syrup PRODUCT INFORMATION. Description. Pharmacology

Package leaflet: Information for the patient. Amoxicilline/Clavulaanzuur Torrent 500 mg/125 mg filmomhulde tabletten. Amoxicillin Clavulanic acid

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

AUGMENTIN ES amoxicillin and clavulanate potassium powder, for suspension GlaxoSmithKline LLC

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

AUGMENTIN ES. Amoxicillin trihydrate - Potassium clavulanate QUALITATIVE AND QUANTITATIVE COMPOSITION

NEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY. PRODUCT INFORMATION ALPHAMOX Amoxicillin (as trihydrate)

Summary of Product Characteristics

Approach to pediatric Antibiotics

APO-CEPHALEXIN POWDER FOR SUSPENSION

Simplicef is Used to Treat Animals with Skin Infections

NEW ZEALAND DATA SHEET. Each powder for oral suspension contains 125 mg or 250 mg of amoxicillin (as trihydrate) per 5 ml when reconstituted.

Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the:

November 2017 Review Nov Signatures of those developing the Patient Group Direction Job Title Name Signature Date Doctor Stephanie Dundas

APO-CEPHALEXIN CAPSULES

New Zealand Data Sheet

SUMMARY OF PRODUCT CHARACTERISTICS AND LABEL/LEAFLET

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. PHEXIN BD TABLETS 375 mg / 750 mg

CLAMOXYL DUO 400 SUSPENSION PRODUCT INFORMATION (Amoxycillin Trihydrate and Potassium Clavulanate)

Amoxicillin clavulanic acid spectrum

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

4 CLINICAL PARTICULARS

Protein Synthesis Inhibitors

APO-AMOXYCILLIN / CLAVULANIC ACID 500/125 TABLETS

SEPTEMBER 2017 DRUG ANTIBIOTICS COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

CEPHALEXIN CAPSULES USP Rx only

SUMMARY OF PRODUCT CHARACTERISTICS

Job Title Name Signature Date

notification of entry onto webpage Document Links

Package leaflet: Information for the user

Policy: These standing orders allow eligible health care ptoviders to treat persons exposed to anthrax.

Irish Medicines Board

SUMMARY OF PRODUCT CHARACTERISTICS

Dilip ver01 10-March-16 1:00 PM

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

Chapter 9: Antiinfective Medications Edmunds: Introduction to Clinical Pharmacology, 8th Edition

Alprim Trimethoprim PRODUCT INFORMATION NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY. Active ingredient: Trimethoprim

SUMMARY OF PRODUCT CHARACTERISTICS

Bacterial skin and soft tissues infections (SSTI) are one of the most common 1. infections among different age groups

SUMMARY OF PRODUCT CHARACTERISTICS

Amoxicillin dose for gum infection

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Package leaflet: Information for the user Augmentin 875 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

PRODUCT MONOGRAPH. (Amoxicillin Trihydrate) Capsules ANTIBIOTIC MYLAN-AMOXICILLIN. 85 Advance Road June 8, Etobicoke, Ontario.

AMOXIL brand of amoxicillin capsules, tablets, chewable tablets, and powder for oral suspension

PRODUCT MONOGRAPH. Amoxicillin and Clavulanic Acid Tablets USP

Package leaflet: Information for the patient. Germentin 500 mg/125 mg film coated tablets Amoxicillin/clavulanic acid

CEPHALEXIN FOR ORAL SUSPENSION USP. Rx only

Developed By Name Signature Date

Other Beta - lactam Antibiotics

SUMMARY OF PRODUCT CHARACTERISTICS

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

Intravenous Antibiotic Therapy Information Leaflet

Transcription:

Amoxicillin Introduction: A semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many gram-positive and gram-negative microganisms. Mechanism of action: Amoxicillin binds to penicillin-binding protein 1A (PBP-1A) located inside the bacterial cell well. Penicillins acylate the penicillin-sensitive transpeptidase C- terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the fmation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that amoxicllin interferes with an autolysin inhibit. Pharmacology: Amoxicillin is a moderate-spectrum antibiotic active against a wide range of Gram-positive, and a limited range of Gram-negative ganisms. It is usually the drug of choice within the class because it is better absbed, following al administration, than other betalactam antibiotics. Amoxicillin is susceptible to degradation by β-lactamase-producing bacteria, and so may be given with clavulanic acid to increase its susceptability. The incidence of β- lactamase-producing resistant ganisms, including E. coli, appears to be increasing. Amoxicillin is sometimes combined with clavulanic acid, a β-lactamase inhibit, to increase the spectrum of action against Gram-negative ganisms, and to overcome bacterial antibiotic resistance mediated through β-lactamase production. Indications: Capsules, chewable tablets, and al suspensions of amoxicillin may be given without regard to meals. The 400-mg suspension, 400-mg chewable tablet, and the 875-mg tablet have been studied only when administered at the start of a light meal. However, food effect studies have not been perfmed with the 200-mg and 500-mg fmulations. Dosage: Neonates and Infants Age 12 Weeks ( 3 Months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of AMOXICILLIN is 30 mg/kg/day divided q12h.

Adults and Pediatric Patients >3 Months Infection Severity * Usual Adult Dose Usual Dose f Children >3 Months Ear/Nose/Throat 500 mg every 250 mg 25 mg/kg/day in divided doses every divided doses Severe hours 500 mg Lower Respiraty Tract Severe hours 500 mg Skin/Skin Structure 500 mg every 12 hours 250 mg 25 mg/kg/day in

Severe hours 500 mg Genitourinary Tract 500 mg every 12 hours 250 mg 25 mg/kg/day in Severe hours 500 mg Gonrhea Acute, uncomplicated anogenital and urethral infections in males and females 3 grams as single al dose Prepubertal children: 50 mg/kg AMOXICILLIN, combined with 25 mg/kg probenecid as a single dose. Side effects: As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are me likely to occur in individuals who have previously demonstrated hypersensitivity to penicillins and in those with a histy of allergy, asthma, hay fever, urticaria. The following adverse reactions have been repted as associated with the use of penicillins: Infections and Infestations: Mucocutaneous candidiasis. Gastrointestinal: Nausea, vomiting, diarrhea, black hairy tongue, and hemrhagic/pseudomembranous colitis. Hypersensitivity Reactions: Anaphylaxis Serum sickness-like reactions, erythematous maculopapular rashes, erythema multifme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, acute

generalized exanthematous pustulosis, hypersensitivity vasculitis and urticaria have been repted. Liver: A moderate rise in AST (SGOT) and/ ALT (SGPT) has been noted, but the significance of this finding is unknown. Hepatic dysfunction including cholestatic jaundice, hepatic cholestasis and acute cytolytic hepatitis have been repted. Renal: Crystalluria has also been repted Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis has been repted during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena. Central Nervous System: Reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavial changes, and/ dizziness have been repted rarely. Miscellaneous: Tooth discolation (brown, yellow, gray staining) has been rarely repted. Most repts occurred in pediatric patients. Discolation was reduced eliminated with brushing dental cleaning in most cases. Precautions: General: The possibility of superinfections with mycotic bacterial pathogens should be kept in mind during therapy. If superinfections occur, amoxicillin should be discontinued and appropriate therapy instituted. A high percentage of patients with mononucleosis who receive ampicillin develop an

erythematous skin rash. Thus, ampicillin-class antibiotics should not be administered to patients with mononucleosis. Pregnancy: Teratogenic Effects: There are no adequate and well-controlled studies in pregnant women, this drug should be used during pregnancy only if clearly needed. Nursing Mothers: Amoxicillin use by nursing mothers may lead to sensitization of infants. Caution should be exercised when amoxicillin is administered to a nursing woman. Pediatric Use: Because of incompletely developed renal function in neonates and young infants, the elimination of amoxicillin may be delayed. Dosing of amoxicillin should be modified in pediatric patients 12 weeks younger ( 3 months). Geriatric Use: This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are me likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monit renal function. Contraindication: A histy of allergic reaction to any of the penicillins is a contraindication. How supplied: Customized as per Request.